The CLASP Lab is directed by Dr. Kyle Minor.
The Cognition, Language, and Affect in Serious Psychopathology (CLASP) laboratory focuses on implementing innovative methodologies to measure and treat psychosis symptoms both inside the laboratory and in daily life.
Psychotic disorders, such as schizophrenia, account for an annual disease burden of $150 billion in the United States alone. Psychotic symptoms are multifaceted and heterogeneous--making them difficult to identify and treat.
As part of CLASP's mission, our team develops instruments that accurately assess psychotic symptoms and creates interventions to improve the lives of people with psychosis. Our work occurs across different stages of the psychosis spectrum (e.g., schizotypy, clinical high risk, first episode, chronic psychosis).